A double-blind placebo control pilot study on the safety and tolerability of Nabilone in marijuana users

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/17523281.2012.693520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 698 OPIATE SPARING EFFECTS OF CANNABINOID IN REFRACTORY CRPS PATIENTS

  2009cited by this paper
• Nabilone for the treatment of pain in fibromyalgia.

  2008cited by this paper
• Cannabinoids in the management of difficult to treat pain

  2008cited by this paper
• A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting

  2008cited by this paper
• Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

  2007cited by this paper
• Marijuana Dependence and Its Treatment

  2007cited by this paper
• The cannabis withdrawal syndrome

  2006cited by this paper
• Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.

  2006cited by this paper
• Cannabinoids in medicine: A review of their therapeutic potential.

  2006cited by this paper
• The marijuana withdrawal syndrome: Diagnosis and treatment

  2005cited by this paper
• Cannabis withdrawal in adolescent treatment seekers.

  2005cited by this paper
• Review of the validity and significance of cannabis withdrawal syndrome.

  2004cited by this paper
• Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

  2004cited by this paper
• Treatment of marijuana dependence: a review of the literature.

  2003cited by this paper
• The time course and significance of cannabis withdrawal.

  2003cited by this paper
• Relapse in outpatient treatment for marijuana dependence.

  2003cited by this paper
• Nefazodone decreases anxiety during marijuana withdrawal in humans

  2002cited by this paper
• Development and Consequences of Cannabis Dependence

  2002cited by this paper
• Marijuana abstinence effects in marijuana smokers maintained in their home environment.

  2001cited by this paper
• Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans

  2001cited by this paper
• Bupropion SR worsens mood during marijuana withdrawal in humans

  2001cited by this paper
• Treating opioid dependence--new data and new opportunities.

  2000cited by this paper
• The cost-effectiveness of substance abuse treatment

  1999cited by this paper
• Marijuana withdrawal among adults seeking treatment for marijuana dependence.

  1999cited by this paper
• Health aspects of cannabis: revisited.

  1998cited by this paper
• Marijuana use and treatment outcome among opioid-dependent patients.

  1998cited by this paper
• An evaluation of the history of a marijuana withdrawal syndrome in a large population.

  1996cited by this paper
• A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.

  1996cited by this paper
• Health aspects of cannabis.

  1986cited by this paper

• Pharmacotherapies for cannabis use disorder.

  2025cites this paper
• Pain and the Thermally Injured Patient—A Review of Current Therapies

  2015cites this paper
• Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting

  2014cites this paper